The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study

Phenylketonuria (PKU) is a metabolic disorder leading to a deficiency in the metabolism of phenylalanine (Phe). Elevated Phe levels in the blood, tissue and brain may lead to emotional, cognitive, and physical symptoms in adults. To control blood Phe levels, most individuals with PKU need to follow...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European journal of health economics 2022-08, Vol.23 (6), p.993-1005
Hauptverfasser: Olofsson, Sara, Gralén, Katarina, Hoxer, Christina, Okhuoya, Paul, Persson, Ulf
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1005
container_issue 6
container_start_page 993
container_title The European journal of health economics
container_volume 23
creator Olofsson, Sara
Gralén, Katarina
Hoxer, Christina
Okhuoya, Paul
Persson, Ulf
description Phenylketonuria (PKU) is a metabolic disorder leading to a deficiency in the metabolism of phenylalanine (Phe). Elevated Phe levels in the blood, tissue and brain may lead to emotional, cognitive, and physical symptoms in adults. To control blood Phe levels, most individuals with PKU need to follow a strict, life-long Phe-restricted diet. The main objective of this study was to estimate the impact of PKU-related disease symptoms and dietary restrictions on health-related quality of life (HRQoL). This study was designed as a web-based survey using the methods of Time Trade-Off (TTO) and Discrete Choice Experiment with duration (DCE TTO ) in a survey of the Swedish general population and population with PKU. Data were collected using questionnaires for TTO diet ( n  = 509), TTO symptoms ( n  = 507), and DCE TTO ( n  = 1117). The disutility of diet restrictions ranged from 0.050 for a partially restricted diet without medical food to 0.193 for a fully restricted diet with medical food in the TTO (DCE: 0.043–0.108). The disutility of experiencing symptoms (emotional, cognitive and physical) ranged from 0.148 for mild symptoms to 0.593 for severe symptoms in the TTO (DCE: 0.122–1.522). The study shows that both diet and symptoms have a significant negative impact on HRQoL in PKU and that utility estimates are largely consistent across methods and samples.
doi_str_mv 10.1007/s10198-021-01415-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2604467449</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2692478443</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-26cd7bc3a5e541e6f29a9ab1a7c2e559a8ca9bb9993bd6bff50970c39cf60af93</originalsourceid><addsrcrecordid>eNp9kcFu1zAMxisEEmPwApwiceFSlqRp2nBDE4NJk7iMc-SmDv-MNumSVNCX4VlJKdMkDpxs2T9_tvVV1WtG3zFKu4vEKFN9TTmrKROsrdWT6oxJ1tedpOzpQ96q_nn1IqU7SjnveHNW_bo9IXHzAiaT4Mn9CpPLGwmWTM7iHkeHmURMOTqTXfCJgB9LNSEkJGmblxzmUkwpGAcZR_LD5RNZTui36Tvm4Nfo4D0Bkt2MJEcYsQ7WPsiYiBmJOQVnkODPBWPBfCYpr-P2snpmYUr46m88r75efby9_FzffPl0ffnhpjZC8FxzacZuMA202AqG0nIFCgYGneHYtgp6A2oYlFLNMMrB2paqjppGGSspWNWcV28P3SWG-7U8q-dyGU4TeAxr0lxSIWQnxI6--Qe9C2v05bpCKS66XoimUPygTAwpRbR6KX9B3DSjerdMH5bpYpn-Y5nepckxhCZ4lx5HeqYkbVW36zYHkkrTf8P4uP0_wr8BU2Snsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2692478443</pqid></control><display><type>article</type><title>The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study</title><source>SpringerNature Journals</source><creator>Olofsson, Sara ; Gralén, Katarina ; Hoxer, Christina ; Okhuoya, Paul ; Persson, Ulf</creator><creatorcontrib>Olofsson, Sara ; Gralén, Katarina ; Hoxer, Christina ; Okhuoya, Paul ; Persson, Ulf</creatorcontrib><description>Phenylketonuria (PKU) is a metabolic disorder leading to a deficiency in the metabolism of phenylalanine (Phe). Elevated Phe levels in the blood, tissue and brain may lead to emotional, cognitive, and physical symptoms in adults. To control blood Phe levels, most individuals with PKU need to follow a strict, life-long Phe-restricted diet. The main objective of this study was to estimate the impact of PKU-related disease symptoms and dietary restrictions on health-related quality of life (HRQoL). This study was designed as a web-based survey using the methods of Time Trade-Off (TTO) and Discrete Choice Experiment with duration (DCE TTO ) in a survey of the Swedish general population and population with PKU. Data were collected using questionnaires for TTO diet ( n  = 509), TTO symptoms ( n  = 507), and DCE TTO ( n  = 1117). The disutility of diet restrictions ranged from 0.050 for a partially restricted diet without medical food to 0.193 for a fully restricted diet with medical food in the TTO (DCE: 0.043–0.108). The disutility of experiencing symptoms (emotional, cognitive and physical) ranged from 0.148 for mild symptoms to 0.593 for severe symptoms in the TTO (DCE: 0.122–1.522). The study shows that both diet and symptoms have a significant negative impact on HRQoL in PKU and that utility estimates are largely consistent across methods and samples.</description><identifier>ISSN: 1618-7598</identifier><identifier>EISSN: 1618-7601</identifier><identifier>DOI: 10.1007/s10198-021-01415-9</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Blood ; Diet ; Dietary restrictions ; Economic Policy ; Health Care Management ; Health Economics ; Medical foods ; Medicine ; Medicine &amp; Public Health ; Metabolic disorders ; Original Paper ; Pharmacoeconomics and Health Outcomes ; Phenylketonuria ; Public Finance ; Public Health ; Quality of life</subject><ispartof>The European journal of health economics, 2022-08, Vol.23 (6), p.993-1005</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-26cd7bc3a5e541e6f29a9ab1a7c2e559a8ca9bb9993bd6bff50970c39cf60af93</citedby><cites>FETCH-LOGICAL-c442t-26cd7bc3a5e541e6f29a9ab1a7c2e559a8ca9bb9993bd6bff50970c39cf60af93</cites><orcidid>0000-0003-2609-2065</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10198-021-01415-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10198-021-01415-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Olofsson, Sara</creatorcontrib><creatorcontrib>Gralén, Katarina</creatorcontrib><creatorcontrib>Hoxer, Christina</creatorcontrib><creatorcontrib>Okhuoya, Paul</creatorcontrib><creatorcontrib>Persson, Ulf</creatorcontrib><title>The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study</title><title>The European journal of health economics</title><addtitle>Eur J Health Econ</addtitle><description>Phenylketonuria (PKU) is a metabolic disorder leading to a deficiency in the metabolism of phenylalanine (Phe). Elevated Phe levels in the blood, tissue and brain may lead to emotional, cognitive, and physical symptoms in adults. To control blood Phe levels, most individuals with PKU need to follow a strict, life-long Phe-restricted diet. The main objective of this study was to estimate the impact of PKU-related disease symptoms and dietary restrictions on health-related quality of life (HRQoL). This study was designed as a web-based survey using the methods of Time Trade-Off (TTO) and Discrete Choice Experiment with duration (DCE TTO ) in a survey of the Swedish general population and population with PKU. Data were collected using questionnaires for TTO diet ( n  = 509), TTO symptoms ( n  = 507), and DCE TTO ( n  = 1117). The disutility of diet restrictions ranged from 0.050 for a partially restricted diet without medical food to 0.193 for a fully restricted diet with medical food in the TTO (DCE: 0.043–0.108). The disutility of experiencing symptoms (emotional, cognitive and physical) ranged from 0.148 for mild symptoms to 0.593 for severe symptoms in the TTO (DCE: 0.122–1.522). The study shows that both diet and symptoms have a significant negative impact on HRQoL in PKU and that utility estimates are largely consistent across methods and samples.</description><subject>Blood</subject><subject>Diet</subject><subject>Dietary restrictions</subject><subject>Economic Policy</subject><subject>Health Care Management</subject><subject>Health Economics</subject><subject>Medical foods</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic disorders</subject><subject>Original Paper</subject><subject>Pharmacoeconomics and Health Outcomes</subject><subject>Phenylketonuria</subject><subject>Public Finance</subject><subject>Public Health</subject><subject>Quality of life</subject><issn>1618-7598</issn><issn>1618-7601</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp9kcFu1zAMxisEEmPwApwiceFSlqRp2nBDE4NJk7iMc-SmDv-MNumSVNCX4VlJKdMkDpxs2T9_tvVV1WtG3zFKu4vEKFN9TTmrKROsrdWT6oxJ1tedpOzpQ96q_nn1IqU7SjnveHNW_bo9IXHzAiaT4Mn9CpPLGwmWTM7iHkeHmURMOTqTXfCJgB9LNSEkJGmblxzmUkwpGAcZR_LD5RNZTui36Tvm4Nfo4D0Bkt2MJEcYsQ7WPsiYiBmJOQVnkODPBWPBfCYpr-P2snpmYUr46m88r75efby9_FzffPl0ffnhpjZC8FxzacZuMA202AqG0nIFCgYGneHYtgp6A2oYlFLNMMrB2paqjppGGSspWNWcV28P3SWG-7U8q-dyGU4TeAxr0lxSIWQnxI6--Qe9C2v05bpCKS66XoimUPygTAwpRbR6KX9B3DSjerdMH5bpYpn-Y5nepckxhCZ4lx5HeqYkbVW36zYHkkrTf8P4uP0_wr8BU2Snsg</recordid><startdate>20220801</startdate><enddate>20220801</enddate><creator>Olofsson, Sara</creator><creator>Gralén, Katarina</creator><creator>Hoxer, Christina</creator><creator>Okhuoya, Paul</creator><creator>Persson, Ulf</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>OQ6</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>M0C</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYYUZ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2609-2065</orcidid></search><sort><creationdate>20220801</creationdate><title>The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study</title><author>Olofsson, Sara ; Gralén, Katarina ; Hoxer, Christina ; Okhuoya, Paul ; Persson, Ulf</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-26cd7bc3a5e541e6f29a9ab1a7c2e559a8ca9bb9993bd6bff50970c39cf60af93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood</topic><topic>Diet</topic><topic>Dietary restrictions</topic><topic>Economic Policy</topic><topic>Health Care Management</topic><topic>Health Economics</topic><topic>Medical foods</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic disorders</topic><topic>Original Paper</topic><topic>Pharmacoeconomics and Health Outcomes</topic><topic>Phenylketonuria</topic><topic>Public Finance</topic><topic>Public Health</topic><topic>Quality of life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Olofsson, Sara</creatorcontrib><creatorcontrib>Gralén, Katarina</creatorcontrib><creatorcontrib>Hoxer, Christina</creatorcontrib><creatorcontrib>Okhuoya, Paul</creatorcontrib><creatorcontrib>Persson, Ulf</creatorcontrib><collection>ECONIS</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Access via ABI/INFORM (ProQuest)</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Global</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ABI/INFORM Collection China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The European journal of health economics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Olofsson, Sara</au><au>Gralén, Katarina</au><au>Hoxer, Christina</au><au>Okhuoya, Paul</au><au>Persson, Ulf</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study</atitle><jtitle>The European journal of health economics</jtitle><stitle>Eur J Health Econ</stitle><date>2022-08-01</date><risdate>2022</risdate><volume>23</volume><issue>6</issue><spage>993</spage><epage>1005</epage><pages>993-1005</pages><issn>1618-7598</issn><eissn>1618-7601</eissn><abstract>Phenylketonuria (PKU) is a metabolic disorder leading to a deficiency in the metabolism of phenylalanine (Phe). Elevated Phe levels in the blood, tissue and brain may lead to emotional, cognitive, and physical symptoms in adults. To control blood Phe levels, most individuals with PKU need to follow a strict, life-long Phe-restricted diet. The main objective of this study was to estimate the impact of PKU-related disease symptoms and dietary restrictions on health-related quality of life (HRQoL). This study was designed as a web-based survey using the methods of Time Trade-Off (TTO) and Discrete Choice Experiment with duration (DCE TTO ) in a survey of the Swedish general population and population with PKU. Data were collected using questionnaires for TTO diet ( n  = 509), TTO symptoms ( n  = 507), and DCE TTO ( n  = 1117). The disutility of diet restrictions ranged from 0.050 for a partially restricted diet without medical food to 0.193 for a fully restricted diet with medical food in the TTO (DCE: 0.043–0.108). The disutility of experiencing symptoms (emotional, cognitive and physical) ranged from 0.148 for mild symptoms to 0.593 for severe symptoms in the TTO (DCE: 0.122–1.522). The study shows that both diet and symptoms have a significant negative impact on HRQoL in PKU and that utility estimates are largely consistent across methods and samples.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s10198-021-01415-9</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-2609-2065</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1618-7598
ispartof The European journal of health economics, 2022-08, Vol.23 (6), p.993-1005
issn 1618-7598
1618-7601
language eng
recordid cdi_proquest_miscellaneous_2604467449
source SpringerNature Journals
subjects Blood
Diet
Dietary restrictions
Economic Policy
Health Care Management
Health Economics
Medical foods
Medicine
Medicine & Public Health
Metabolic disorders
Original Paper
Pharmacoeconomics and Health Outcomes
Phenylketonuria
Public Finance
Public Health
Quality of life
title The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A46%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20on%20quality%20of%20life%20of%20diet%20restrictions%20and%20disease%20symptoms%20associated%20with%20phenylketonuria:%20a%20time%20trade-off%20and%20discrete%20choice%20experiment%20study&rft.jtitle=The%20European%20journal%20of%20health%20economics&rft.au=Olofsson,%20Sara&rft.date=2022-08-01&rft.volume=23&rft.issue=6&rft.spage=993&rft.epage=1005&rft.pages=993-1005&rft.issn=1618-7598&rft.eissn=1618-7601&rft_id=info:doi/10.1007/s10198-021-01415-9&rft_dat=%3Cproquest_cross%3E2692478443%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2692478443&rft_id=info:pmid/&rfr_iscdi=true